Where the investigating committee1 has considered a fitness to practise or a disqualification allegation2 and decided not to refer it to the committee and within five years from the date of service of the notice sent to the registrant3, the General Pharmaceutical Council4 receives a new allegation about the person concerned, the investigating committee may take the action specified below5.
The investigating committee may:
(1) when considering whether or not to refer the new allegation to the fitness to practise committee, have regard to the original allegation6; and
(2) may refer both the original allegation and the new allegation to
**Trials are provided to all LexisPSL and LexisLibrary content, excluding Practice Compliance, Practice Management and Risk and Compliance, subscription packages are tailored to your specific needs. To discuss trialling these LexisPSL services please email customer service via our online form. Free trials are only available to individuals based in the UK. We may terminate this trial at any time or decide not to give a trial, for any reason. Trial includes one question to LexisAsk during the length of the trial.
To view the latest version of this document and millions of others like it, sign-in to LexisLibrary or register for a free trial.
EXISTING USER? SIGN IN
TAKE A FREE TRIAL
0330 161 1234